Pricing

Glyscend Incorporated

0 followers

‌

Founded in 2014, Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes.

Industries

Biotechnology

Headquarters

Baltimore, United States

Employees

11-50

Links

Org chart

Sapan Shah

CEO

Sapan Shah

Collapse

Ashish Nimgaonkar

Chief Medical Officer & Head, R&D

Mark Fineman

Chief Development Officer

John Petersen

VP, CMC

Kevin Colbert

Senior Director, Operations & Strategy

Bob Soh

Director

Christine Bryant

Senior Director Clinical & Translational Science

Teams

Advisory Team

10 members

Research and Development Team

4 members

Leadership Team

3 members

Similar companies

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Halda Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

Thermo Fisher Scientific

157 followers

CRISPR Therapeutics

9 followers

Adverum Biotech

8 followers

Legend Biotech

5 followers

Artivion

3 followers

Verve Therapeutics

54 followers

ImmunityBio

2 followers

Explore companies